Civic Center Pharmacy Inc.

CLOSEOUT LETTER Civic Center Pharmacy Inc. MARCS-CMS 453724 — April 02, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: SIGNATURE CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Tenille D. Davis Recipient Title Pharmacist In Charge Civic Center Pharmacy Inc. 7331 E. Osborn Drive Suite 208 Scottsdale , AZ 85251-6420 United States Issuing Office: Center for Drug Evaluation and Research 19701 Fairchild Irvine , CA 92612-2506 United States 949-608-2900 Dear Dr. Davis: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #32-15 dated August 20, 2015. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Steven E. Porter, Jr. Director, Division of Pharmaceutical Quality Operations IV Content current as of: 08/14/2019 Regulated Product(s) Drugs